Ligand-promoted protein folding by biased kinetic partitioning

Nat Chem Biol. 2017 Apr;13(4):369-371. doi: 10.1038/nchembio.2303. Epub 2017 Feb 20.

Abstract

Protein folding in cells occurs in the presence of high concentrations of endogenous binding partners, and exogenous binding partners have been exploited as pharmacological chaperones. A combined mathematical modeling and experimental approach shows that a ligand improves the folding of a destabilized protein by biasing the kinetic partitioning between folding and alternative fates (aggregation or degradation). Computationally predicted inhibition of test protein aggregation and degradation as a function of ligand concentration are validated by experiments in two disparate cellular systems.

MeSH terms

  • 1-Deoxynojirimycin / analogs & derivatives
  • 1-Deoxynojirimycin / metabolism
  • 1-Deoxynojirimycin / pharmacology
  • Escherichia coli / chemistry
  • Escherichia coli / genetics
  • Escherichia coli / metabolism
  • HEK293 Cells
  • Humans
  • Kinetics
  • Ligands*
  • Models, Molecular
  • Molecular Chaperones / pharmacology*
  • Protein Aggregates / drug effects*
  • Protein Folding / drug effects*
  • Proteolysis / drug effects*
  • Reproducibility of Results
  • Tetrahydrofolate Dehydrogenase / chemistry
  • Tetrahydrofolate Dehydrogenase / metabolism
  • Trimethoprim / metabolism
  • Trimethoprim / pharmacology
  • alpha-Galactosidase / chemistry
  • alpha-Galactosidase / metabolism

Substances

  • Ligands
  • Molecular Chaperones
  • Protein Aggregates
  • 1-Deoxynojirimycin
  • Trimethoprim
  • migalastat
  • Tetrahydrofolate Dehydrogenase
  • GLA protein, human
  • alpha-Galactosidase